loader2
Partner With Us NRI

May 24, 2022

Category

Others

AUM (Cr.)

86.53

Exit Load (%)

0.00

Min Inv Lumpsum

1,000

Expense Ratio

0.19

Sharpe Ratio

-5.39

Beta Ratio

0.00

Fund Manager

Mehul Dama

Inception Date

Jul 06, 2021

Risk Level

Very High

Investment Objective

The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.

Invest Now
Nifty Pharma TRI

Return Calculator

Investment Type

SIP Lumpsum

Company

Period(Year)

Amount

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - Nippon India Nifty Pharma ETF -6.47 -5.18 0 0 0 -11.49
Benchmark - Nifty Pharma TRI -5.01 -4.21 -7.26 15.81 6.72 0
Category Average - BEST ETFS/INDEX -5.92 -7.25 3.55 10.02 9.47 17.05
Category Rank 5/1 3/1 4/1 3/1 1/1 1/1
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
SBI ETF Gold 45.5489 9,877.85 -98.95 -74.87 -55.78 2,580.61 0.64 5,000.00 invest
Motilal Oswal NASDAQ-100 ETF 91.1992 1.49 -4.42 22.25 20.04 5,258.19 0.58 10,000.00 invest
Motilal Oswal Nasdaq Q 50 ETF 49.3516 0.37 0.00 0.00 0.00 16.42 0.41 500.00 invest
Mirae Asset Nifty Financial Services ETF 15.8440 0.32 0.00 0.00 0.00 153.65 0.00 5,000.00 invest
Nippon India ETF Liquid BeES 1,000.0000 -57.46 3.11 1.44 0.87 4,417.57 0.65 2,500,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)		 4 Months Trends
Equity-Sun Pharma.Inds. Apr 30, 2022 19.55 22.59 1.22
Equity-Divi`s Lab. Apr 30, 2022 11.19 12.93 2.05
Equity-Cipla Apr 30, 2022 9.88 11.41 -3.90
Equity-Dr Reddy`s Labs Apr 30, 2022 9.79 11.31 -4.09
Equity-Laurus Labs Apr 30, 2022 4.46 5.16 -1.43
Equity-Lupin Apr 30, 2022 3.50 4.04 -0.61
Equity-Aurobindo Pharma Apr 30, 2022 3.45 3.99 -6.18
Equity-Gland Pharma Apr 30, 2022 3.28 3.79 -2.45
Equity-Biocon Apr 30, 2022 3.28 3.79 9.47
Equity-Alkem Lab Apr 30, 2022 3.11 3.59 -10.49

latest news

Nippon India Passive Flexicap FOF Announces change in Fund Managers

Nippon India Mutual Fund has announced change in Fund Managers under Nippon...

May 17, 2022 09:46

Nippon India Balanced Advantage Fund Announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 12 May 2022 as the record date for d...

May 07, 2022 09:08

Nippon India Balanced Advantage Fund Announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 12 April 2022 as the record date for...

Apr 07, 2022 09:22

Nippon India Mutual Fund Announces merger of Nippon India Fixed Horizon Fund XXXIX Series 8 into Nippon India Short Term Fund

Nippon India Mutual Fund and Nippon Life India Asset Management Private Lim...

Apr 04, 2022 09:06

Nippon India Mutual Fund Announces merger of Nippon India Fixed Horizon Fund XXXX Series 15 into Nippon India Short Term Fund

Nippon India Mutual Fund and Nippon Life India Asset Management Private Lim...

Apr 02, 2022 09:43

Nippon India Mutual Fund Announces merger of under its schemes

Nippon India Mutual Fund and Nippon Life India Asset Management Private Lim...

Apr 01, 2022 10:25

SCHEME DETAILS

AMC Name : Nippon India Mutual Fund
Fund Name : Nippon India Nifty Pharma ETF
Contact Persone : Mehul Dama
Registered Address : 4th Floor, Tower A, Peninsula Busines-s Park, Ganapatrao Kadam MargLower Parel (W), Mumbai - 400013.
Telephone No : 022-68087000/1860260111
Fax No. : 022-68087097
Email : customercare:nipponindiaim.in
Website : mf.nipponindiaim.com